Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide
Authors
Keywords
-
Journal
STATISTICS IN MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-05-18
DOI
10.1002/sim.8569
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reference‐based sensitivity analysis for time‐to‐event data
- (2019) Andrew Atkinson et al. PHARMACEUTICAL STATISTICS
- A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome
- (2019) Ian R. White et al. Journal of Biopharmaceutical Statistics
- Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis
- (2019) Susan Chan et al. JAMA Pediatrics
- Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial
- (2018) Liana K. Billings et al. DIABETES CARE
- Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease
- (2018) Alireza Atri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Controlled pattern imputation for sensitivity analysis of longitudinal binary and ordinal outcomes with nonignorable dropout
- (2018) Yongqiang Tang STATISTICS IN MEDICINE
- Information-anchored sensitivity analysis: theory and application
- (2018) Suzie Cro et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY
- Control-based imputation for sensitivity analyses in informative censoring for recurrent event data
- (2017) Fei Gao et al. PHARMACEUTICAL STATISTICS
- The role of anti-IgE (omalizumab/Xolair) in the management of severe recalcitrant paediatric atopic eczema (ADAPT): statistical analysis plan
- (2017) Tao Chen et al. Trials
- Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial
- (2017) Susan Chan et al. Trials
- Internet-accessed sexually transmitted infection (e-STI) testing and results service: A randomised, single-blind, controlled trial
- (2017) Emma Wilson et al. PLOS MEDICINE
- Sensitivity to censored-at-random assumption in the analysis of time-to-event endpoints
- (2016) Ilya Lipkovich et al. PHARMACEUTICAL STATISTICS
- Does intensive multimodal treatment for maternal ADHD improve the efficacy of parent training for children with ADHD? A randomized controlled multicenter trial
- (2015) Thomas Jans et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Sensitivity analyses for partially observed recurrent event data
- (2015) Mouna Akacha et al. PHARMACEUTICAL STATISTICS
- Comparison Between Two Controlled Multiple Imputation Methods for Sensitivity Analyses of Time-to-Event Data With Possibly Informative Censoring
- (2015) Kaifeng Lu et al. Statistics in Biopharmaceutical Research
- Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder
- (2015) Alexandra Philipsen et al. JAMA Psychiatry
- Handling missing data in RCTs; a review of the top medical journals
- (2014) Melanie L Bell et al. BMC Medical Research Methodology
- Choosing sensitivity analyses for randomised trials: principles
- (2014) Tim P Morris et al. BMC Medical Research Methodology
- Response to Comments by Seaman et al. on “Analysis of Longitudinal Trials With Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation,”Journal of Biopharmaceutical Statistics23:1352–1371
- (2014) J. R. Carpenter et al. Journal of Biopharmaceutical Statistics
- A Multiple-Imputation-Based Approach to Sensitivity Analyses and Effectiveness Assessments in Longitudinal Clinical Trials
- (2014) Birhanu Teshome Ayele et al. Journal of Biopharmaceutical Statistics
- Comment on “Analysis of Longitudinal Trials With Protocol Deviations: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation,” by Carpenter, Roger, and Kenward
- (2014) Shaun R. Seaman et al. Journal of Biopharmaceutical Statistics
- Missing data sensitivity analysis for recurrent event data using controlled imputation
- (2014) Oliver N. Keene et al. PHARMACEUTICAL STATISTICS
- Relaxing the independent censoring assumption in the Cox proportional hazards model using multiple imputation
- (2014) Dan Jackson et al. STATISTICS IN MEDICINE
- A review of the handling of missing longitudinal outcome data in clinical trials
- (2014) Matthew Powney et al. Trials
- Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation
- (2013) James R. Carpenter et al. Journal of Biopharmaceutical Statistics
- Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models
- (2013) Bohdana Ratitch et al. PHARMACEUTICAL STATISTICS
- An analytic method for the placebo-based pattern-mixture model
- (2013) Kaifeng Lu STATISTICS IN MEDICINE
- Recent Developments in the Prevention and Treatment of Missing Data
- (2013) C. Mallinckrodt et al. Therapeutic Innovation & Regulatory Science
- Multiple imputation using chained equations: Issues and guidance for practice
- (2010) Ian R. White et al. STATISTICS IN MEDICINE
- Missing Data Handling Methods in Medical Device Clinical Trials
- (2009) Xu Yan et al. Journal of Biopharmaceutical Statistics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now